Clinical Trials
4 trialsNCT04114136 2026-04-24
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Phase 2 Recruiting
NCT00098852 2014-01-06
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01100619 2013-09-19
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
Exelixis
Phase 1 Completed
NCT00369174 2013-02-13
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed